G protein-coupled receptor
5-HT2C receptor
5-hydroxytryptamine receptor 2C
- GeneHTR2C
- FamilySerotonin receptors
- Group5-HT2 receptors
The 5-HT2C receptor was first called 5-HT1C. It was described as a serotonin binding site in the choroid plexus of the pig brain, and its cDNA was later cloned from the choroid plexus of the rat. Like the other 5-HT2 receptors, it is a G protein-coupled receptor.1,2,3 It was moved from the 5-HT1 family to the 5-HT2 family once it had been cloned and its characteristics were known. Activation of the receptor increases the activity of phospholipase C in the choroid plexus of several species and in transfected cells, through a G protein.4,5 In cells that carry the human receptor, agonists cause a rapid rise in calcium inside the cell.6
The receptor was first found in the choroid plexus, where it is very abundant and may help to regulate the exchange of ions between the brain and the cerebrospinal fluid. It is also widely distributed in the brain, and its mRNA is very high in the retrosplenial, piriform and entorhinal cortex, the anterior olfactory nucleus, the lateral septal nucleus, the subthalamic nucleus, the amygdala, the subiculum, the lateral habenula, the substantia nigra pars compacta, several brainstem nuclei and the whole grey matter of the spinal cord. The mRNA turned up in more places than the binding sites, and the authors concluded that this is a principal serotonin receptor of the brain. Unlike the 5-HT2A and 5-HT2B receptors, it has little evidence of expression outside the central nervous system.7,8,4 The mRNAs of the 5-HT2A and the 5-HT2C receptor are found in distinct but overlapping sets of regions. Both are high in the anterior olfactory nucleus, the piriform cortex, the endopiriform nucleus, the claustrum, the ventral part of CA3, the substantia nigra pars compacta and several brainstem nuclei. In the caudate-putamen both are present but with different distributions.8
Its messenger RNA is edited in a tissue-specific way, which gives several forms of the receptor. Editing can make the receptor interact 10 to 15 times less efficiently with its G proteins.9
Mice that lack the receptor become overweight because their feeding behaviour is no longer controlled normally, and they are prone to spontaneous, sometimes fatal seizures.3 Later work followed the weight gain of these mice. They eat more food although they respond normally to leptin. Their weight departs from that of normal mice after about 20 weeks of age, and at 42 weeks they are on average 30 percent heavier. Older mutants develop insulin resistance and impaired glucose tolerance, and a high-fat diet leads to high blood glucose without high blood lipids.10 In animal studies all 5-HT2C agonists decrease food intake, while antagonists and inverse agonists can cause weight gain in rodents and humans. In most animal studies selective antagonists did not increase food intake on their own, and they did not cause seizures. The faults of the knockout mice may therefore partly arise during development and not only from the loss of the receptor in the adult.11,7,4
Lorcaserin, a selective 5-HT2C agonist, was developed to lower body weight and was approved in the United States in 2012. In a year-long placebo-controlled trial with 3182 obese or overweight adults, 47.5 percent of those taking lorcaserin lost at least 5 percent of their body weight, against 20.3 percent on placebo, an average of 5.8 kg against 2.2 kg. Valve disease was not more frequent. This mattered because the older drugs fenfluramine and dexfenfluramine had raised the risk of valve disease, an effect thought to come from agonism of the 5-HT2B receptor. The most frequent side effects were headache, dizziness and nausea.12,13 In 2020 the FDA asked the manufacturer to withdraw lorcaserin from the US market. A large postmarketing trial with 12,000 patients, which was not designed to test cancer, showed more cancer diagnoses with lorcaserin than with placebo. The FDA counted 990 cancer diagnoses in 885 patients, and 7.7 percent of the patients on lorcaserin and 7.1 percent on placebo were diagnosed with cancer. Colorectal, pancreatic and lung cancer were notably more frequent with lorcaserin. Combined with other serotonergic drugs, lorcaserin also seems to carry a risk of serotonin syndrome, and its safety in that setting has not been established.13,11
Many antipsychotics, antidepressants and anxiolytics bind to the receptor. Both agonists and antagonists have been proposed for anxiety, depression and schizophrenia, an apparent paradox that the authors of a review link to the animal models used and to the multiple and competing actions of the receptor in the brain. In the case of antipsychotics, blocking the 5-HT2C receptor appears to diminish some of the actions of blocking the 5-HT2A receptor.11,14
Sources (14)
- Pazos et al. 1984Pazos A, Hoyer D, Palacios JM (1984) The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site Eur J Pharmacol
- Julius et al. 1988Julius D, MacDermott AB, Axel R, et al. (1988) Molecular characterization of a functional cDNA encoding the serotonin 1c receptor Science
- Tecott et al. 1995Tecott LH, Sun LM, Akana SF, et al. (1995) Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors Nature
- Barnes et al. 1999Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function Neuropharmacology
- Barnes et al. 2021Barnes NM, Ahern GP, Becamel C, et al. (2021) International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function Pharmacol Rev
- Porter et al. 1999Porter RH, Benwell KR, Lamb H, et al. (1999) Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells Br J Pharmacol
- Nichols et al. 2008Nichols DE, Nichols CD (2008) Serotonin receptors Chem Rev
- Pompeiano et al. 1994Pompeiano M, Palacios JM, Mengod G (1994) Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors Brain Res Mol Brain Res
- Burns et al. 1997Burns CM, Chu H, Rueter SM, et al. (1997) Regulation of serotonin-2C receptor G-protein coupling by RNA editing Nature
- Nonogaki et al. 1998Nonogaki K, Strack AM, Dallman MF, et al. (1998) Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene Nat Med
- Di Giovanni et al. 2016Di Giovanni G, De Deurwaerdère P (2016) New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders Pharmacology & Therapeutics
- Smith et al. 2010Smith SR, Weissman NJ, Anderson CM, et al. (2010) Multicenter, placebo-controlled trial of lorcaserin for weight management N Engl J Med
- Sharretts et al. 2020Sharretts J, Galescu O, Gomatam S, et al. (2020) Cancer Risk Associated with Lorcaserin - The FDA's Review of the CAMELLIA-TIMI 61 Trial N Engl J Med
- Meltzer 1999Meltzer HY (1999) The role of serotonin in antipsychotic drug action Neuropsychopharmacology
Binding affinity (Kᵢ)
28 substances, 38 displayed values. Strongest first within each organism. The bar is pKᵢ on a log scale. Open a row to see the assay and every report behind the value.
Human
28 measurements
DOB1.3 nMNelson et al. 1999
- Assay
- cloned human 5-HT2C receptor in AV12 cells; agonist-radioligand [125I]DOI binding
- Shown value from
- Nelson et al. 1999, Table 1
- Error
- ± 0.20 SEM, n = 3
Values depend on the assay, species or conditions, and each is valid only for its own. 2 reports in all, 1.3–42 nM.
DOI2.4 nMNelson et al. 1999 · 3 reports
- Assay
- cloned human 5-HT2C receptor in AV12 cells; agonist-radioligand [125I]DOI binding
- Shown value from
- Nelson et al. 1999, Table 1
- Range
- 2.4–46 nM in 3 reports
- Error
- ± 0.30 SEM, n = 3
Values depend on the assay, species or conditions, and each is valid only for its own. 4 reports in all, 2.4–46 nM.
Sources and values behind the range, same assay family Report Value Where Nelson et al. 1999 2.4 nM Table 1 Jain et al. 2025 46 nM Table S4 Glatfelter et al. 2022 41 nM Table 1 ALD-5210 nMHalberstadt et al. 2020
- Assay
- cloned human 5-HT2C receptor; [3H]mesulergine competition
- Shown value from
- Halberstadt et al. 2020, Table 1
- Error
- ± 3.5 SEM, n = 3
DOM19 nMEshleman et al. 2018 · 5 reports
- Assay
- recombinant human 5-HT2C receptor; [125I]DOI competition binding
- Shown value from
- Eshleman et al. 2018, Table 1
- Range
- 19–404 nM in 5 reports
- Error
- ± 2.4 SEM, n = 4
This is the best-supported value. Other reports differ. 6 reports in all, 19–3980 nM.
Sources and values behind the range, same assay family Report Value Where Luethi et al. 2026 404 nM Table 1 Eshleman et al. 2018 19 nM Table 1 Janowsky et al. 2014 26 nM Table 1 Jain et al. 2025 220 nM Table S4 Eshleman et al. 2014 26 nM Table 2 2C-I40 nMRickli et al. 2015
- Assay
- cloned human receptor (HEK293)
- Shown value from
- Rickli et al. 2015, Table 1
- Error
- ± 9.0 SD
Values depend on the assay, species or conditions, and each is valid only for its own. 2 reports in all, 10–40 nM.
2C-P40 nMRickli et al. 2015
- Assay
- cloned human receptor (HEK293)
- Shown value from
- Rickli et al. 2015, Table 1
- Error
- ± 5.0 SD
LSD45 nMHalberstadt et al. 2020 · 6 reports
- Assay
- cloned human 5-HT2C receptor; [3H]mesulergine competition
- Shown value from
- Halberstadt et al. 2020, Table 1
- Range
- 1.3–45 nM in 6 reports
- Error
- ± 16 SEM, n = 3
Values depend on the assay, species or conditions, and each is valid only for its own. 8 reports in all, 1.3–45 nM.
Sources and values behind the range, same assay family Report Value Where Halberstadt et al. 2020 45 nM Table 1 Jain et al. 2025 17 nM Table S4 Eshleman et al. 2018 1.6 nM Table 1 Janowsky et al. 2014 2.9 nM Table 1 Eshleman et al. 2014 3.2 nM Table 2 Eshleman et al. 2013 1.3 nM Table 5 2C-B47 nMRickli et al. 2015 · 2 reports
- Assay
- cloned human receptor (HEK293)
- Shown value from
- Rickli et al. 2015, Table 1
- Range
- 47–90 nM in 2 reports
- Error
- ± 9.0 SD
Sources and values behind the range, same assay family Report Value Where Ray 2010 90 nM Table S2 (AllKiData) Rickli et al. 2015 47 nM Table 1 ETH-LAD56 nMJain et al. 2025
- Assay
- radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
- Shown value from
- Jain et al. 2025, Table S4
AL-LAD68 nMJain et al. 2025
- Assay
- radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
- Shown value from
- Jain et al. 2025, Table S4
2C-C90 nMRickli et al. 2015
- Assay
- cloned human receptor (HEK293)
- Shown value from
- Rickli et al. 2015, Table 1
- Error
- ± 26 SD
Values depend on the assay, species or conditions, and each is valid only for its own. 2 reports in all, 5.4–90 nM.
Psilocin94 nMRickli et al. 2016 · 4 reports
- Assay
- HEK293 membranes expressing human 5-HT2C; [3H]mesulergine displacement
- Shown value from
- Rickli et al. 2016, Table 1
- Range
- 94–250 nM in 4 reports
- Error
- ± 9.0 SD
Sources and values behind the range, same assay family Report Value Where Rickli et al. 2016 94 nM Table 1 Glatfelter et al. 2022 175 nM Table 1 Jain et al. 2025 250 nM Table S4 Dodd et al. 2023 94 nM Table 2 2C-E100 nMRickli et al. 2015 · 2 reports
- Assay
- cloned human receptor (HEK293)
- Shown value from
- Rickli et al. 2015, Table 1
- Range
- 100–104 nM in 2 reports
- Error
- ± 20 SD
Values depend on the assay, species or conditions, and each is valid only for its own. 3 reports in all, 5.4–104 nM.
Sources and values behind the range, same assay family Report Value Where Ray 2010 104 nM Table S2 (AllKiData) Rickli et al. 2015 100 nM Table 1 2C-D150 nMRickli et al. 2015
- Assay
- cloned human receptor (HEK293)
- Shown value from
- Rickli et al. 2015, Table 1
- Error
- ± 30 SD
Values depend on the assay, species or conditions, and each is valid only for its own. 2 reports in all, 13–150 nM.
4-HO-MET153 nMKozell et al. 2023 · 3 reports
- Assay
- human 5-HT2C receptor in HEK-293 cells; [3H]5-HT competition binding
- Shown value from
- Kozell et al. 2023, Table 1
- Range
- 141–164 nM in 3 reports
- Error
- ± 43 SEM, n = 3
Sources and values behind the range, same assay family Report Value Where Rickli et al. 2016 141 nM Table 1 Kozell et al. 2023 153 nM Table 1 Glatfelter et al. 2023 164 nM Table 2 Bufotenin210 nMJain et al. 2025
- Assay
- radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
- Shown value from
- Jain et al. 2025, Table S4
DMT234 nMKozell et al. 2023 · 5 reports
- Assay
- human 5-HT2C receptor in HEK-293 cells; [3H]5-HT competition binding
- Shown value from
- Kozell et al. 2023, Table 1
- Range
- 111–424 nM in 5 reports
- Error
- ± 16 SEM, n = 22
This is the best-supported value. Other reports differ. 6 reports in all, 111–424 nM.
Sources and values behind the range, same assay family Report Value Where Rickli et al. 2016 424 nM Table 1 Kozell et al. 2023 234 nM Table 1 Janowsky et al. 2014 166 nM Table 1 Jain et al. 2025 260 nM Table S4 Eshleman et al. 2014 111 nM Table 2 5-MeO-DMT266 nMGlatfelter et al. 2024 · 2 reports
- Assay
- human 5-HT2C receptor, [3H]mesulergine competition binding
- Shown value from
- Glatfelter et al. 2024, Supplement Figure S1
- Range
- 266–490 nM in 2 reports
Sources and values behind the range, same assay family Report Value Where Jain et al. 2025 490 nM Table S4 Glatfelter et al. 2024 266 nM Supplement Figure S1 6-APB270 nMRickli et al. 2015
- Assay
- cloned human 5-HT2C receptor binding
- Shown value from
- Rickli et al. 2015, Table 3
- Error
- ± 50 SD
5-MeO-MiPT790 nMKozell et al. 2023 · 3 reports
- Assay
- human 5-HT2C receptor in HEK-293 cells; [3H]5-HT competition binding
- Shown value from
- Kozell et al. 2023, Table 1
- Range
- 790–1601 nM in 3 reports
- Error
- ± 120 SEM, n = 3
Sources and values behind the range, same assay family Report Value Where Rickli et al. 2016 1300 nM Table 1 Kozell et al. 2023 790 nM Table 1 Glatfelter et al. 2024 1601 nM Supplement Figure S1 Psilocybin808 nMGlatfelter et al. 2022 · 2 reports
- Assay
- Transfected-cell radioligand binding at human 5-HT2C (UNC PDSP)
- Shown value from
- Glatfelter et al. 2022, Table 1
- Range
- 808–3100 nM in 2 reports
Reported values disagree and no value is established. 2 reports in all, 808–3100 nM.
Sources and values behind the range, same assay family Report Value Where Glatfelter et al. 2022 808 nM Table 1 Jain et al. 2025 3100 nM Table S4 5-APB880 nMRickli et al. 2015
- Assay
- cloned human 5-HT2C receptor binding
- Shown value from
- Rickli et al. 2015, Table 3
- Error
- ± 330 SD
MDMA1500 nMJain et al. 2025 · 3 reports
- Assay
- radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
- Shown value from
- Jain et al. 2025, Table S4
- Range
- 1360–9600 nM in 3 reports
Reported values disagree and no value is established. 3 reports in all, 1360–9600 nM.
Sources and values behind the range, same assay family Report Value Where Jain et al. 2025 1500 nM Table S4 Eshleman et al. 2014 9600 nM Table 2 Eshleman et al. 2013 1360 nM Table 5 MDA3000 nMRickli et al. 2015
- Assay
- cloned human 5-HT2C receptor binding
- Shown value from
- Rickli et al. 2015, Table 3
- Error
- ± 900 SD
Ephedrine3300 nMRickli et al. 2015
- Assay
- cloned human 5-HT2C receptor binding
- Shown value from
- Rickli et al. 2015, Table 3
- Error
- ± 700 SEM
4-FMA5500 nMRickli et al. 2015
- Assay
- cloned human 5-HT2C receptor binding
- Shown value from
- Rickli et al. 2015, Table 3
- Error
- ± 600 SEM
4-FA7800 nMRickli et al. 2015
- Assay
- cloned human 5-HT2C receptor binding
- Shown value from
- Rickli et al. 2015, Table 3
- Error
- ± 700 SEM
Mephedrone9100 nMEshleman et al. 2013
- Assay
- cells expressing human 5-HT2C, [125I]DOI displacement
- Shown value from
- Eshleman et al. 2013, Table 5
- Error
- ± 2100 SEM, n = 4
Pig
2 measurements
Bufotenin63 nMColas et al. 1997
- Assay
- pig 5-HT2C receptor expressed in COS-1 cells, [125I]DOI competition binding
- Shown value from
- Colas et al. 1997, Table 1
5-MeO-DMT100 nMColas et al. 1997
- Assay
- pig 5-HT2C receptor expressed in COS-1 cells, [125I]DOI competition binding
- Shown value from
- Colas et al. 1997, Table 1
Rat
2 measurements
Psilocin10 nMDodd et al. 2023
- Assay
- 5-HT2C binding, compiled in a review (Table 2), original assay not restated
- Shown value from
- Dodd et al. 2023, Table 2
5-MeO-DMT418 nMHalberstadt et al. 2012
- Assay
- cloned rat receptor; [3H]mesulergine competition binding (NIMH PDSP)
- Shown value from
- Halberstadt et al. 2012, Table 1
- Error
- ± 35 SEM
Unspecified
6 measurements
LSD7.0 nMEgan et al. 2000 · 2 reports
- Assay
- cells stably expressing 5-HT2C, [3H]mesulergine competition (antagonist radioligand, low-affinity state KL)
- Shown value from
- Egan et al. 2000, Table II
- Range
- 7.0–12 nM in 2 reports
- Error
- ± 1.5 SEM, n = 3
Sources and values behind the range, same assay family Report Value Where Egan et al. 2000 7.0 nM Table II Glennon 1987 12 nM Text, section 5 (Ergolines) DOI60 nMEgan et al. 2000
- Assay
- cells stably expressing 5-HT2C, [3H]mesulergine competition (antagonist radioligand, low-affinity state KL)
- Shown value from
- Egan et al. 2000, Table II
- Error
- ± 5.1 SEM, n = 3
Psilocin97 nMDodd et al. 2023
- Assay
- 5-HT2C binding, compiled in a review (Table 2), original assay not restated
- Shown value from
- Dodd et al. 2023, Table 2
Bufotenin145 nMPlazas et al. 2023 · 2 reports
- Assay
- 5-HT2C receptor, compiled in a review table (Table 5), original assay not restated
- Shown value from
- Plazas et al. 2023, Table 5
- Range
- 70–145 nM in 2 reports
Sources and values behind the range, same assay family Report Value Where Glennon 1987 70 nM Table III Plazas et al. 2023 145 nM Table 5 DOB152 nMEgan et al. 2000
- Assay
- cells stably expressing 5-HT2C, [3H]mesulergine competition (antagonist radioligand, low-affinity state KL)
- Shown value from
- Egan et al. 2000, Table II
- Error
- ± 19 SEM, n = 3
DMT360 nMKeiser et al. 2009
- Assay
- NIMH PDSP radioligand competition binding at the 5-HT2C receptor, [3H]LSD (1.0 nM), standard binding buffer
- Shown value from
- Keiser et al. 2009, Supplementary Table 4
Functional potency (EC₅₀)
19 substances, 29 displayed values. Strongest first within each organism. Emax is shown where the paper reports it. Efficacy depends on the assay and its reference agonist.
Human
18 measurements
LSD1.7 nMEshleman et al. 2018 · 2 reports
- Assay
- recombinant human 5-HT2C receptor; IP-1 formation
- Shown value from
- Eshleman et al. 2018, Table 2
- Range
- 0.85–1.7 nM in 2 reports
- Error
- ± 0.29 SEM, n = 3
- Emax
- 92.5 ± 4.8%
Values depend on the assay, species or conditions, and each is valid only for its own. 6 reports in all, 0.85–120 nM.
Sources and values behind the range, same assay family Report Value Where Eshleman et al. 2018 1.7 nM Table 2 Janowsky et al. 2014 0.85 nM Table 2 Bufotenin5.2 nMJain et al. 2025
- Assay
- 5-HT2C receptor, calcium flux (FLIPR Tetra) in tetracycline-inducible Flp-In T-REx 293 cells
- Shown value from
- Jain et al. 2025, Table S6
- Emax
- 88.4 ± 1.6%
DOB7.8 nMPorter et al. 1999
- Assay
- CHO-K1 cells stably expressing recombinant human 5-HT2C VSV isoform; FLIPR calcium mobilization
- Shown value from
- Porter et al. 1999, Table 1
- Emax
- 65.0%
This is the best-supported value. Other reports differ. 5 reports in all, 0.25–66 nM.
DOI7.9 nMPorter et al. 1999 · 3 reports
- Assay
- CHO-K1 cells stably expressing recombinant human 5-HT2C VSV isoform; FLIPR calcium mobilization
- Shown value from
- Porter et al. 1999, Table 1
- Range
- 6.6–48 nM in 3 reports
- Emax
- 57.0%
This is the best-supported value. Other reports differ. 7 reports in all, 0.14–191 nM.
Sources and values behind the range, same assay family Report Value Where Porter et al. 1999 7.9 nM Table 1 Jain et al. 2025 6.6 nM Table S6 Elmore et al. 2018 48 nM Table 1 DOM13 nMJain et al. 2025
- Assay
- 5-HT2C receptor, calcium flux (FLIPR Tetra) in tetracycline-inducible Flp-In T-REx 293 cells
- Shown value from
- Jain et al. 2025, Table S6
- Emax
- 102.2 ± 2.0%
Reported values disagree and no value is established. 11 reports in all, 0.23–1622 nM.
2C-E18 nMEshleman et al. 2014 · 4 reports
- Assay
- HEK-h5-HT2C IP-1 formation
- Shown value from
- Eshleman et al. 2014, Table 2
- Range
- 0.23–18 nM in 4 reports
- Error
- ± 5.9 SEM
- Emax
- 98.0 ± 16.0%
Values depend on the assay, species or conditions, and each is valid only for its own. 4 reports in all, 0.23–18 nM.
Sources and values behind the range, same assay family Report Value Where Ray 2010 0.64 nM, 0.23 nM, 1.1 nM Table S3 Eshleman et al. 2014 18 nM Table 2 5-MeO-DMT23 nMJain et al. 2025 · 3 reports
- Assay
- 5-HT2C receptor, calcium flux (FLIPR Tetra) in tetracycline-inducible Flp-In T-REx 293 cells
- Shown value from
- Jain et al. 2025, Table S6
- Range
- 23–64 nM in 3 reports
- Emax
- 95.4 ± 1.1%
Reported values disagree and no value is established. 7 reports in all, 2.6–64 nM.
Sources and values behind the range, same assay family Report Value Where Cameron et al. 2021 31 nM Extended Data Fig. 5 Jain et al. 2025 23 nM Table S6 Glatfelter et al. 2024 64 nM Supplement Figure S4 Psilocin34 nMGlatfelter et al. 2022 · 3 reports
- Assay
- cells expressing human 5-HT2C; calcium mobilization
- Shown value from
- Glatfelter et al. 2022, Table 4
- Range
- 12–34 nM in 3 reports
- Emax
- 84.0%
This is the best-supported value. Other reports differ. 7 reports in all, 2.0–34 nM.
Sources and values behind the range, same assay family Report Value Where Klein et al. 2020 22 nM Table 3 Glatfelter et al. 2022 34 nM Table 4 Jain et al. 2025 12 nM Table S6 4-HO-MET35 nMKozell et al. 2023
- Assay
- human 5-HT2C receptor in HEK-293 cells; IP-1 formation (Cisbio kit)
- Shown value from
- Kozell et al. 2023, Table 1
- Error
- ± 8.7 SEM, n = 4
- Emax
- 100.7 ± 4.9%
AL-LAD37 nMJain et al. 2025
- Assay
- 5-HT2C receptor, calcium flux (FLIPR Tetra) in tetracycline-inducible Flp-In T-REx 293 cells
- Shown value from
- Jain et al. 2025, Table S6
- Emax
- 100.4 ± 32.1%
2C-I47 nMElmore et al. 2018
- Assay
- HEK293 human 5-HT2C calcium mobilization
- Shown value from
- Elmore et al. 2018, Table 1
- Error
- ± 6.7 SEM
- Emax
- 28.0%
Values depend on the assay, species or conditions, and each is valid only for its own. 4 reports in all, 2.8–540 nM.
2C-D71 nMEshleman et al. 2014
- Assay
- HEK-h5-HT2C IP-1 formation
- Shown value from
- Eshleman et al. 2014, Table 2
- Error
- ± 8.0 SEM
- Emax
- 100.0 ± 14.0%
2C-C78 nMElmore et al. 2018
- Assay
- HEK293 human 5-HT2C calcium mobilization
- Shown value from
- Elmore et al. 2018, Table 1
- Error
- ± 5.5 SEM
- Emax
- 29.0%
Reported values disagree and no value is established. 2 reports in all, 24–78 nM.
ETH-LAD83 nMJain et al. 2025
- Assay
- 5-HT2C receptor, calcium flux (FLIPR Tetra) in tetracycline-inducible Flp-In T-REx 293 cells
- Shown value from
- Jain et al. 2025, Table S6
- Emax
- 95.2 ± 1.9%
DMT104 nMKozell et al. 2023 · 2 reports
- Assay
- human 5-HT2C receptor in HEK-293 cells; IP-1 formation (Cisbio kit)
- Shown value from
- Kozell et al. 2023, Table 1
- Range
- 96–104 nM in 2 reports
- Error
- ± 11 SEM, n = 20
- Emax
- 97.6 ± 2.1%
Sources and values behind the range, same assay family Report Value Where Kozell et al. 2023 104 nM Table 1 Janowsky et al. 2014 96 nM Table 2 5-MeO-MiPT179 nMKozell et al. 2023
- Assay
- human 5-HT2C receptor in HEK-293 cells; IP-1 formation (Cisbio kit)
- Shown value from
- Kozell et al. 2023, Table 1
- Error
- ± 56 SEM, n = 6
- Emax
- 101.2 ± 6.5%
Reported values disagree and no value is established. 6 reports in all, 2.8–745 nM.
MDMA2500 nMJain et al. 2025
- Assay
- 5-HT2C receptor, calcium flux (FLIPR Tetra) in tetracycline-inducible Flp-In T-REx 293 cells
- Shown value from
- Jain et al. 2025, Table S6
- Emax
- 34.6 ± 2.8%
Psilocybin3741 nMGlatfelter et al. 2022
- Assay
- cells expressing human 5-HT2C; calcium mobilization
- Shown value from
- Glatfelter et al. 2022, Table 4
- Emax
- 88.0%
Mouse
2 measurements
Psilocin30 nMPlazas et al. 2023
- Assay
- 5-HT2C receptor, compiled in a review table (Table 5), original assay not restated
- Shown value from
- Plazas et al. 2023, Table 5
Psilocybin506 nMPlazas et al. 2023
- Assay
- 5-HT2C receptor, compiled in a review table (Table 5), original assay not restated
- Shown value from
- Plazas et al. 2023, Table 5
Rat
7 measurements
2C-I71 nMAcuña-Castillo et al. 2002
- Assay
- rat 5-HT2C receptor in Xenopus laevis oocytes; two-electrode voltage clamp (Cl- current)
- Shown value from
- Acuña-Castillo et al. 2002, Table 3
- Error
- ± 26 SEM, n = 5
- Emax
- 44.0 ± 10.0%
DOB102 nMAcuña-Castillo et al. 2002
- Assay
- rat 5-HT2C receptor in Xenopus laevis oocytes; two-electrode voltage clamp (Cl- current)
- Shown value from
- Acuña-Castillo et al. 2002, Table 3
- Error
- ± 26 SEM, n = 6
- Emax
- 58.0 ± 3.0%
DOI178 nMAcuña-Castillo et al. 2002
- Assay
- rat 5-HT2C receptor in Xenopus laevis oocytes; two-electrode voltage clamp (Cl- current)
- Shown value from
- Acuña-Castillo et al. 2002, Table 3
- Error
- ± 46 SEM, n = 6
- Emax
- 90.0 ± 9.0%
DMT220 nMSmith et al. 1998
- Assay
- Rat choroid plexus, [3H]inositol phosphate formation
- Shown value from
- Smith et al. 1998, Results, Fig. 7
- Emax
- 75.0%
DOM423 nMAcuña-Castillo et al. 2002
- Assay
- rat 5-HT2C receptor in Xenopus laevis oocytes; two-electrode voltage clamp (Cl- current)
- Shown value from
- Acuña-Castillo et al. 2002, Table 3
- Error
- ± 209 SEM, n = 5
- Emax
- 81.0 ± 13.0%
2C-B493 nMAcuña-Castillo et al. 2002
- Assay
- rat 5-HT2C receptor in Xenopus laevis oocytes; two-electrode voltage clamp (Cl- current)
- Shown value from
- Acuña-Castillo et al. 2002, Table 3
- Error
- ± 132 SEM, n = 4
- Emax
- 50.0 ± 11.0%
2C-D1308 nMAcuña-Castillo et al. 2002
- Assay
- rat 5-HT2C receptor in Xenopus laevis oocytes; two-electrode voltage clamp (Cl- current)
- Shown value from
- Acuña-Castillo et al. 2002, Table 3
- Error
- ± 793 SEM, n = 5
- Emax
- 48.0 ± 7.0%
Unspecified
2 measurements
LSD0.62 nMBasargin et al. 2026
- Assay
- HEK293T cells transiently expressing 5-HT2C with Gαq-RLuc8, human Gβ3 and GFP2-Gγ9, Gq dissociation BRET2
- Shown value from
- Basargin et al. 2026, SI Table S2, p. S19
- Emax
- 100.5 ± 4.1%
DMT49 nMSmith et al. 1998 · 2 reports
- Assay
- NIH 3T3 fibroblasts expressing the 5-HT2C receptor, [3H]inositol phosphate formation
- Shown value from
- Smith et al. 1998, Results, Fig. 1
- Emax
- 85.0%
Sources and values behind the range, same assay family Report Value Where Cameron et al. 2018 49 nM Table 2 Smith et al. 1998 49 nM Results, Fig. 1
Also reported to act here
Substances reported to act here, without a displayed value.
Values are published numbers in nM per organism. Different assays, species and receptor preparations are not directly interchangeable, and a value does not establish clinical potency or safety.